Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development

Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise INCHEON, South Korea, Jan. 8, 2025 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization…